News

Venom researchers from the Institute for Molecular Bioscience (IMB) have discovered the venom of the assassin bug is like no other venomous animal previously studied.

Therapeutics inspired by venoms could provide the key to treatment for a common gastrointestinal disease if a collaboration between researchers from Institute for Molecular Bioscience and Danish biotech company Zealand Pharma A/S is successful.

A joint University of Queensland and Queensland Health-led team has completed the first genetic analysis of TB strains circulating on PNG’s Daru Island, a major hotspot for TB outbreaks on Australia’s doorstep.

Humans might be the most resilient species on Earth, but until recently, no one could explain how a small population survives the incredibly harsh conditions of the Tibetan Plateau – a lofty, oxygen-starved environment that towers 4.5 km above sea level.

A discovery by Queensland scientists could be the key to stopping damage caused by uncontrolled inflammation in a range of common diseases including liver disease, Alzheimer’s and gout.

Researchers say a major genomic study will provide answers for patients with unexplained kidney disease, and could lead to better treatments.

The Institute for Molecular Bioscience (IMB) has celebrated the graduations of its first PhD students from Serbia and Nepal, who investigated rare neurodegenerative disorders and diagnostic tools for dengue fever.

The Director of The University of Queensland’s Institute for Molecular Bioscience (IMB) will help steer a national initiative striving to double survival rates for people with brain cancer over the next decade.

In the “golden era” of antibiotic drug discovery – 1950 to 1970 – drug companies could afford to be choosy, selecting only the very best candidates for approval.As a result, many potent antibiotics did not make the cut for development and were abandoned. Given the current crisis in antibiotic discovery, the time is right to revisit many of these potentially invaluable molecules in search of antibiotic scaffolds with novel modes of action.

An antibiotic overlooked since its discovery 40 years ago could help develop new drugs against life-threatening infections caused by some of the world’s most dangerous superbugs.

You know the drill. A picnic in the park, a walk in the bush or a barbecue with friends and family – all perfect summer activities that can be ruined by annoying flies that never leave you alone.

So why do they do it and what do they want?

Did you know that when you take certain genetic tests, the company can make money by on-selling your data to other businesses?

Now new blockchain-based marketplaces could give individuals control over access to their encrypted DNA data, and the ability to sell it to research companies for their own profit.

An IMB graduate will use a Fulbright scholarship to study at Stanford University to address some of the world's biggest challenges - how to end poverty, protect the planet and ensure prosperity for all.

Massive banks of genetic information are being harnessed to shed new light on modifiable health risks that underlie common diseases.

University of Queensland researchers have pioneered a method to integrate data from multiple large-scale studies to assess risk factors such as body mass index (BMI) and cholesterol levels, and their association with diseases including type two diabetes and heart disease.

Gardening is a great way to relax, be one with nature and get your hands dirty. But lurking in that pleasant environment are some nasty bacteria and fungi, with the potential to cause you serious harm. So we need to be vigilant with gardening gloves and other protective wear.

An old drug supercharged by University of Queensland researchers has emerged as a new antibiotic that could destroy some of the world’s most dangerous superbugs.

Researchers have new insights into how protective antibodies attack dengue viruses, which could lead to more effective dengue fever vaccines and drug therapies.

The technicians who keep the research machinery running are among recipients of this year’s Institute for Molecular Bioscience (IMB) Impact Awards.

Improving the success rate of heart transplants is among the goals of a University of Queensland researcher, 50 years after the first such surgery was performed in South Africa.

A University of Queensland PhD student will spend 2018 undertaking research and training in sophisticated imaging techniques to better understand how promising Parkinson’s disease drugs enter the brain.